Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status (Q34607133)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23457626

retrieved

3 August 2017

title

Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23457626

retrieved

3 August 2017

main subject

ductal carcinoma

1 reference

based on heuristic

inferred from title

breast ductal carcinoma

1 reference

based on heuristic

inferred from title

author

Gillian Farnie

object named as

Gillian Farnie

series ordinal

1

0 references

Robert B. Clarke

object named as

Robert B Clarke

series ordinal

3

0 references

author name string

Pamela M Willan

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23457626

retrieved

3 August 2017

Nigel J Bundred

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23457626

retrieved

3 August 2017

language of work or name

English

0 references

publication date

14 February 2013

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23457626

retrieved

3 August 2017

published in

PLOS One

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23457626

retrieved

3 August 2017

volume

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23457626

retrieved

3 August 2017

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23457626

retrieved

3 August 2017

page(s)

e56840

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23457626

retrieved

3 August 2017

copyright license

Creative Commons Attribution 4.0 International

start time

14 February 2013

1 reference

stated in

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572946

retrieved

7 July 2018

Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572946

retrieved

7 July 2018

Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572946

retrieved

7 July 2018

Synthetic lethality through combined Notch-epidermal growth factor receptor pathway inhibition in basal-like breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572946

retrieved

7 July 2018

Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572946

retrieved

7 July 2018

Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572946

retrieved

7 July 2018

Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572946

retrieved

7 July 2018

HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572946

retrieved

7 July 2018

Recent advances and current controversies in the management of DCIS of the breast

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572946

retrieved

7 July 2018

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572946

retrieved

7 July 2018

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572946

retrieved

7 July 2018

Ductal carcinoma in situ, complexities and challenges.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572946

retrieved

7 July 2018

Prospective identification of tumorigenic breast cancer cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572946

retrieved

7 July 2018

Stem cells, cancer, and cancer stem cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572946

retrieved

7 July 2018

ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572946

retrieved

7 July 2018

Cancer Stem Cells and Radiotherapy: New Insights Into Tumor Radioresistance

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0056840

retrieved

21 January 2018

Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23457626

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Gro

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23457626

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23457626

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23457626

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1371/JOURNAL.PONE.0056840

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23457626

retrieved

3 August 2017

ADS bibcode

2013PLoSO...856840F

0 references

PMC publication ID

3572946

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23457626

retrieved

3 August 2017

PubMed publication ID

23457626

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23457626

retrieved

3 August 2017

ResearchGate publication ID

235778554

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34607133&oldid=1994335328"